TENOFOVIR DISOPROXIL FUMARATE
NDC 62135-466, TENOFOVIR DISOPROXIL FUMARATE Tablets, tablet, film coated, from Chartwell RX, LLC..
- Product NDC
- 62135-466
- Status
- Listed
- Labeler
- Chartwell RX, LLC.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206481
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-466 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TENOFOVIR DISOPROXIL FUMARATE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-466-30 | 62135046630 | 30 TABLET, FILM COATED in 1 BOTTLE (62135-466-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9cf11bd3-01b9-4ac8-96cc-55d57998b51dNADAC price for package 62135046630
GET /v1/drugs/nadac/62135046630
Use it
Look up 62135-466 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-466 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-466. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.